Advances in molecular genetics of panic disorder (Q37667843)

21 August 2017

1 reference

title

Advances in molecular genetics of panic disorder (English)

1 reference

21 August 2017

1 reference

E Maron

1

1 reference

21 August 2017

J M Hettema

series ordinal

2

1 reference

21 August 2017

J Shlik

series ordinal

3

1 reference

21 August 2017

language of work or name

English

0 references

publication date

5 January 2010

1 reference

21 August 2017

1 reference

21 August 2017

15

1 reference

21 August 2017

7

1 reference

21 August 2017

681-701

1 reference

https://scigraph.springernature.com/pub.10.1038/mp.2009.145

21 August 2017

0 references

cites work

The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

A Population-Based Twin Study of the Relationship Between Neuroticism and Internalizing Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

A cognitive approach to panic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Neuroanatomical hypothesis of panic disorder, revised

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

A review and meta-analysis of the genetic epidemiology of anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Linkage on chromosome 14 in a genome-wide linkage study of a broad anxiety phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

The genetic basis of panic and phobic anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Arginine-vasopressin and oxytocin response to cholecystokinin-tetrapeptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Rgs 2 gene polymorphisms as modulators of anxiety in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association analysis of Rgs7 variants with panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

RGS2 and generalized anxiety disorder in an epidemiologic sample of hurricane-exposed adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

A third-pass genome scan in panic disorder: evidence for multiple susceptibility loci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Prefrontal cortical gamma-aminobutyric Acid levels in panic disorder determined by proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Reduced gamma-aminobutyric acid(A)-benzodiazepine binding sites in insular cortex of individuals with panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association study of 90 candidate gene polymorphisms in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Investigation of cholecystokinin system genes in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Identification of a compound short tandem repeat stretch in the 5'-upstream region of the cholecystokinin gene, and its association with panic disorder but not with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: strong evidence for a chromosome 4 risk locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association of cholecystokinin-A receptor gene polymorphisms and panic disorder in Japanese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association between the CCK-A receptor gene and panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association of a functional 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association study between the serotonin 1A receptor (HTR1A) gene and neuroticism, major depression, and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Reduced serotonin type 1A receptor binding in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

An association analysis of murine anxiety genes in humans implicates novel candidate genes for anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association analysis of the functional Ala111Glu polymorphism of the glyoxalase I gene in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Bayesian analysis of a previously published genome screen for panic disorder reveals new and compelling evidence for linkage to chromosome 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Gender-specific association of a functional coding polymorphism in the Neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Anxiety with panic disorder linked to chromosome 9q in Iceland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Identification of prosaposin as a neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Regulation of gene expression in response to brain injury: enhanced expression and alternative splicing of rat prosaposin (SGP-1) mRNA in injured brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Human nuclear transcription factor gene CREM: genomic organization, mutation screening, and association analysis in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Investigation of polymorphisms in the CREM gene in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association between a functional polymorphism in the progesterone receptor gene and panic disorder in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association of polymorphisms in P2RX7 and CaMKKb with anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Tryptophan hydroxylase-2 controls brain serotonin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

The novel brain-specific tryptophan hydroxylase-2 gene in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

A tryptophan hydroxylase 2 gene polymorphism is associated with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association study of tryptophan hydroxylase 2 gene polymorphisms in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Panic disorder, social anxiety disorder, and a possible medical syndrome previously linked to chromosome 13

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Investigation of the DAOA/G30 locus in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

G72 and its association with major depression and neuroticism in large population-based groups from Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association study of serotonin-2A receptor gene polymorphism and panic disorder in patients from Canada and Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

The association between serotonin-related gene polymorphisms and panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Stimulation of 5-HT1A or 5-HT2A receptors in the ventrolateral periaqueductal gray causes anxiolytic-, but not panicolytic-like effect in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Alprazolam potentiates the antiaversive effect induced by the activation of 5-HT(1A) and 5-HT (2A) receptors in the rat dorsal periaqueductal gray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

A chromosome 14 risk locus for simple phobia: results from a genomewide linkage scan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

The bradykinin B2 receptor mediates hypoxia/reoxygenation induced neuronal cell apoptosis through the ERK1/2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

No evidence for DUP25 in patients with panic disorder using a quantitative real-time PCR approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Failure to find DUP25 in patients with anxiety disorders, in control individuals, or in previously reported positive control cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Genome-wide linkage scan for loci predisposing to social phobia: evidence for a chromosome 16 risk locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Associations between serotonin-related gene polymorphisms and panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Lack of association between the Serotonin Transporter Promoter Polymorphism (5-HTTLPR) and Panic Disorder: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis, clinical features and treatment outcome of panic disorder in the Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Anxiety-like behavior in mice lacking the angiotensin II type-2 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Angiotensin-II is a putative neurotransmitter in lactate-induced panic-like responses in rats with disruption of GABAergic inhibition in the dorsomedial hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Lack of association between angiotensin I-converting enzyme insertion/deletion gene functional polymorphism and panic disorder in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association and linkage analysis of candidate genes GRP, GRPR, CRHR1, and TACR1 in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Polymorphisms of the human homologue of the Drosophila white gene are associated with mood and panic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Increased anxiogenic effects of caffeine in panic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association study of A2a adenosine receptor genetic polymorphism in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

The association between panic disorder and the L/L genotype of catechol-O-methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Catechol-O-methyltransferase contributes to genetic susceptibility shared among anxiety spectrum phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Evidence that variation in the peripheral benzodiazepine receptor (PBR) gene influences susceptibility to panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

A highly significant association between a COMT haplotype and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Whole genome linkage scan of recurrent depressive disorder from the depression network study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

A linkage search for joint panic disorder/bipolar genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Spurious genetic associations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Molecular studies of major depressive disorder: the epigenetic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Allele C-specific methylation of the 5-HT2A receptor gene: evidence for correlation with its expression and expression of DNA methylase DNMT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

The quantification of COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Gene discovery through imaging genetics: identification of two novel genes associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Identification of loci associated with schizophrenia by genome-wide association and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Whole-genome association study of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Meta-analysis of two genome-wide association studies of bipolar disorder reveals important points of agreement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

A whole genome association study of neuroticism using DNA pooling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Genomewide association analysis followed by a replication study implicates a novel candidate gene for neuroticism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Psychiatric genetics: progress amid controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Genome-wide association study of panic disorder in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Pathways-based analyses of whole-genome association study data in bipolar disorder reveal genes mediating ion channel activity and synaptic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association between A2a receptor gene polymorphisms and caffeine-induced anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Lack of relationship between CO2 reactivity and serotonin transporter gene regulatory region polymorphism in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pretreatment in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Transcriptional profiling of lymphoblast lines from subjects with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

High cholesterol levels in patients with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Delayed increase in LDL cholesterol following pentagastrin-induced panic attacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Dysfunctional baroreflex regulation of sympathetic nerve activity in remitted patients with panic disorder. A new methodological approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

beta-adrenoceptor affinity as a biological predictor of treatment response to paroxetine in patients with acute panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Is the association of hypertension and panic disorder explained by clustering of autonomic panic symptoms in hypertensive patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Panic disorder and control of breathing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Anxiety sensitivity: theoretical perspectives and recent findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Discomfort intolerance: evaluation of a potential risk factor for anxiety psychopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Brain circuits in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Neurobiology of panic disorder: from animal models to brain neuroimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Integrated defence reaction elicited by excitatory amino acid microinjection in the midbrain periaqueductal grey region of the unrestrained cat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Neural pathways underlying lactate-induced panic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

COMT Val158Met and cognition: main effects and interaction with educational attainment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Impact of interacting functional variants in COMT on regional gray matter volume in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association between the catechol O-methyltransferase Val108/158Met polymorphism and alexithymia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Large recurrent microdeletions associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Brain-specific small nucleolar RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Norepinephrine transporter (NET) promoter and 5'-UTR polymorphisms: association analysis in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Linkage genome scan for loci predisposing to panic disorder or agoraphobia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Findings in an independent sample support an association between bipolar affective disorder and the G72/G30 locus on chromosome 13q33

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

A Polymorphic Genomic Duplication on Human Chromosome 15 Is a Susceptibility Factor for Panic and Phobic Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

No association between DUP25 and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

5′ UTR-region SNP in the NTRK3 gene is associated with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Excess of High Activity Monoamine Oxidase A Gene Promoter Alleles in Female Patients with Panic Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

β2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

A Comparison of Fluvoxamine, Cognitive Therapy, and Placebo in the Treatment of Panic Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

What makes a good genetic association study?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

Association of polymorphisms in the angiotensin-converting enzyme gene with syndromal panic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

A population-based twin study of the relationship between neuroticism and internalizing disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Genomewide survey of panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR).

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Association of a Met88Val diazepam binding inhibitor (DBI) gene polymorphism and anxiety disorders with panic attacks

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Impaired Repression at a 5-Hydroxytryptamine 1A Receptor Gene Polymorphism Associated with Major Depression and Suicide

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Early response to selective serotonin reuptake inhibitors in panic disorder is associated with a functional 5-HT1A receptor gene polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Results of a genome-wide genetic screen for panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Genetics of panic disorder on the Faroe Islands: a replication study of chromosome 9 and panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Potential panic disorder syndrome: Clinical and genetic linkage evidence

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Combining cognitive testing and informant report to increase accuracy in screening for dementia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Blunted growth hormone responses to growth hormone-releasing factor and to clonidine in panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

No association between anxiety disorders and catechol-O-methyltransferase polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Catechol O-methyltransferase genetic polymorphism in panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

No genetic linkage or association between a functional promoter polymorphism in the monoamine oxidase-A gene and panic disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Genome-wide association study of recurrent major depressive disorder in two European case–control cohorts

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Evaluating gene x psychological risk factor effects in the pathogenesis of anxiety: a new model approach.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Differential gene expression in peripheral blood of patients suffering from post-traumatic stress disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Peripheral gene expression profiling of CCK-4-induced panic in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

High cholesterol levels in patients with sleep panic

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Paroxetine, Clomipramine, and Cognitive Therapy in the Treatment of Panic Disorder

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

5-HT and mechanisms of defence

1 reference

https://api.crossref.org/works/10.1038%2FMP.2009.145

7 January 2021

Identifiers

DOI

10.1038/MP.2009.145

1 reference

Dimensions Publication ID

21 August 2017

0 references

1 reference